EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma

Jinan He iD, Rui Miao, Yao Chen, Han Wang iD, Mei Liu

Immunology · 2024-04 · 171 (4) · 445-463

DOI: 10.1111/imm.13738 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 14.12.2023. Verfasst von Jinan He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Chronic, Liver Neoplasms, Hepatitis B. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a major contributor to cancer‐related deaths worldwide. Hepatitis B virus (HBV) infection is a major etiologic factor leading to HCC. While there have been significant advancements in controlling HBV replication, achieving a complete cure for HBV‐related HCC (HBV‐HCC) remains an intricate challenge. HBV persistence is attributed to a myriad of mechanisms, encompassing both innate and adaptive immune responses. Regulatory T cells (Tregs) are pivotal in upholding immune tolerance and modulating excessive immune activation. During HBV infection, Tregs mediate specific T cell suppression, thereby contributing to both persistent infection and the mitigation of liver inflammatory responses. Studies have demonstrated an augmented expression of circulating and intrahepatic Tregs in HBV‐HCC, which correlates with impaired CD8 + T cell function. Consequently, Tregs play a dual role in the context of HBV infection and the progression of HBV‐HCC. In this comprehensive review, we discuss pertinent studies concerning Tregs in HBV infection, HBV‐related cirrhosis and HCC. Furthermore, we summarize Treg responses to antiviral therapy and provide Treg‐targeted therapies specific to HBV and HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis B, ChronicLiver NeoplasmsHepatitis BHumansHepatitis B virusT-Lymphocytes, Regulatory

Stichwörter der Autor:innen

hepatitis B virushepatocellular carcinomaimmunosuppression mechanismsimmunotherapyregulatory T cells

Autor:innen und Institutionen

  • Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Guangzhou Women and Children Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Department of Internal Medicine, Northeast Yunnan Regional Central Hospital, Zhaotong, Yunan, China.
  • Hubei Key Laboratory of Hepato-Biliary-Pancreatic Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Jinan He, Han Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

He, J., Miao, R., Chen, Y., Wang, H., & Liu, M. (2024). The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma. Immunology, 171(4), 445-463. https://doi.org/10.1111/imm.13738

Vancouver

He J, Miao R, Chen Y, Wang H, Liu M. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma. Immunology. 2024;171(4):445-463. doi:10.1111/imm.13738

BibTeX
@article{He2024,
  author = {He, Jinan and Miao, Rui and Chen, Yao and Wang, Han and Liu, Mei},
  title = {The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma},
  journal = {Immunology},
  year = {2024},
  volume = {171},
  number = {4},
  pages = {445--463},
  doi = {10.1111/imm.13738}
}
Kostenlos starten →